Type 2 Diabetes Mellitus in Obese Clinical Trial
Official title:
Prospective Interventional Study on Reversibility of Type 2 Diabetes Mellitus With Hypocaloric Diet
T2DM, a chronic progressive disorder has an epidemic status in India. Remission (HbA1c of < 6.5% without any anti-diabetic medication) of T2DM is achievable with diet modifications in recently diagnosed obese T2D individuals. Studies suggest Very Low Calorie Diet (600 - 800kcal) and Low Calorie Diet-LCD (800 -1000 kcal) using Meal replacers (MR) are helpful. The investigators aimed to study the effects of LCD without any anti diabetic medication in intervention group and later comparing it with Control group (on standard medical treatment).
The objective is to study the effect of LCD in anthropometric , biochemical and NAFLD (Non
Alcholic Fatty Liver Disease) parameters after 8 weeks and 24 weeks from enrollment.
Purposive sampling is used to enroll participants in the study. The LCD is a combination of
one meal replacer and modified major meals. Calculated exchanges of food groups is taken care
of in the other two major meals and snacks in between. Inorder to adhere compliance clinical
(at baseline, after 8 weeks, after 24 weeks) as well as virtual visits through whatsapp,
e-mails, SMS, phone calls (once a week during 8 weeks of intervention and further once a
month upto 24 weeks) are scheduled. After 8 weeks of LCD, calorie is increased to 1200-1400
Kcal/day. In the control group the standard medical treatment is continued.
The data is collected in case report form and analysed using SPSS software by statistician.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05606471 -
Glucagon-like Peptide-1 Agonism With Very Low Calorie Diets
|
Phase 4 | |
| Completed |
NCT05072990 -
Type 2 Diabetes Mellitus With Obesity and Dyslipidemia Treated by Chinese Herbal Medicine
|
||
| Withdrawn |
NCT02977039 -
Effect of a Plant Rich Diet on in People With Type 2 Diabetes and Obesity
|
N/A | |
| Recruiting |
NCT06223490 -
Effect of Cryolipolysis on Insulin Resistance
|
N/A | |
| Recruiting |
NCT05277558 -
Brain Health in Youth With Normal Weight, Overweight and Obesity at Risk for Type 2 Diabetes (T2D)
|
||
| Recruiting |
NCT04621929 -
Obesity and Uric Acid Stones Study
|
Phase 3 | |
| Completed |
NCT04332354 -
Glycemic Profile by CGMS in Diabetic Patients After Bariatric Surgery
|
||
| Completed |
NCT05890950 -
A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of K-757 and K-833 in Overweight/Obese Patients With Type 2 Diabetes
|
Phase 1 | |
| Not yet recruiting |
NCT06442150 -
LCMD for Type 2 Diabetes Remission: Evaluation of Effectiveness and Exploration of Individual Differences
|
N/A | |
| Withdrawn |
NCT04910997 -
Heart Rate Variability-Guided Exercise Training in Type 2 Diabetes
|
N/A | |
| Completed |
NCT04931836 -
The Influence of Physical Activity on the Gut Microbiome of Pre-Diabetic Adults
|
N/A | |
| Recruiting |
NCT06005012 -
Semaglutide Treatment in the Real-world for Fibrosis Due to NAFLD in Obesity and T2DM
|
Phase 2 | |
| Completed |
NCT05409027 -
A Study to Assess 11 Beta-hydroxysteroid Dehydrogenase Type 1 Inhibition in Adipose Tissue by SPI-62
|
Phase 1 | |
| Terminated |
NCT04741074 -
Effect of Subcutaneous Semaglutide on Kidney Transplant Candidacy
|
Phase 3 | |
| Recruiting |
NCT05838287 -
Pioglitazone on Heart Failure in Type-2 Diabetes Mellitus Participants
|
Phase 4 | |
| Active, not recruiting |
NCT04916314 -
REmote SUpport for Low-Carbohydrate Treatment of Type 2 Diabetes
|
N/A | |
| Completed |
NCT04303819 -
The Effect of Exenatide on Fasting Bile Acids
|
||
| Recruiting |
NCT05446415 -
L-Cell Activity in Small Intestine as Biliopancreatic Loop in Obese Patients With DM2 Submitted to RYGBP
|
N/A | |
| Completed |
NCT05770076 -
Probiotic Lysate (Postbiotic and Metabiotic) Supplementation for Type 2 Diabetes Patients (DELI_Diab Study)
|
N/A | |
| Completed |
NCT02937987 -
Dietary Intake, Eating Behavior, Physical Activity Level and Their Relationships With Glycemic and Weight Control in Hong Kong Chinese Type 2 Diabetic Patients
|